The global human vaccine market size is expected to reach at US$ 84 billion by 2030 and is projected to grow at a CAGR of 9.1% from 2021 to 2030.
The extremely low risk of serious and fatal side effects, education and awareness through various governmental and non-profit organizations, growing preference for outsourcing of vaccine manufacturing are projected to drive the global human vaccine market during the forecast period.
Vaccination is the most effective measure for the prevention and control of a number of human and animal diseases. It has saved lives of millions of children, adults and animals, and provided them a better and healthier life.
Vaccination is an easier and less risky approach as compared to medicines to prevent a number of diseases from occurring in humans as well as animals. According to a study on the economic impact of routine childhood immunization in the U.S., every dollar spent on vaccination saves approximately US$ 5 in direct cost and nearly US$ 11 in additional cost to the society.
Growing Preference for Outsourcing of HPAPI Manufacturing to Drive Market
Conjugate Vaccines Segment to Dominate Market
Meningococcal Vaccine to be Highly Lucrative Segment
North America to Dominate Global Market
The global human vaccine market has been segmented as follows:
By Vaccine Type
By Distribution Channel
By Age Group
Scope of Report
The Human vaccines market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Human vaccines market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Human vaccines market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human vaccines market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Human vaccines market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Human vaccines capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Human vaccines by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Human vaccines market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Human vaccines market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Human vaccines market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Human vaccines industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
Human vaccines market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Human vaccines market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Human vaccines market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Human vaccines market. These factors have benefited the growth of the global market for Human vaccines. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Human vaccines. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Human vaccines are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Table of Contents
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Human Vaccine Market
4. Market Overview
4.3. Market Dynamics
4.4. Global Human Vaccine Market Analysis and Forecasts, 2018–2030
5. Key Insights
5.1. Product Overview
5.2. Key Industry Developments
5.3. Emerging Trends in Human Vaccines Market
6. Global Human Vaccine Market Analysis and Forecasts, By Vaccine
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Vaccine, 2018–2030
6.4. Market Attractiveness By Vaccine
7. Global Human Vaccine Market Analysis and Forecasts, By Product
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Product, 2018–2030
7.3.7. Measles and Rubella
7.4. Market Attractiveness By Product
8. Global Human Vaccine Market Analysis and Forecasts, By Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Distribution Channel, 2018–2030
8.3.1. Hospital Pharmacies
8.4. Market Attractiveness By Distribution Channel
9. Global Human Vaccine Market Analysis and Forecasts, By Age Group
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By Age Group, 2018–2030
9.4. Market Attractiveness By Age Group
10. Global Human Vaccine Market Analysis and Forecasts, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Region
11. North America Human Vaccine Market Analysis and Forecast
11.2. Market Value Forecast By Vaccine, 2018–2030
11.3. Market Value Forecast By Product, 2018–2030
11.3.7. Measles and Rubella
11.4. Market Value Forecast By Distribution Channel, 2018–2030
11.4.1. Hospital Pharmacies
11.5. Market Value Forecast By Age Group, 2018–2030
11.6. Market Value Forecast By Country, 2018–2030
11.7. Market Attractiveness Analysis
11.7.1. By Vaccine
11.7.2. By Product
11.7.3. By Distribution Channel
11.7.4. By Age Group
11.7.5. By Country
12. Europe Human Vaccine Market Analysis and Forecast
12.2. Market Value Forecast By Vaccine, 2018–2030
12.3. Market Value Forecast By Product, 2018–2030
12.3.7. Measles and Rubella
12.4. Market Value Forecast By Distribution Channel, 2018–2030
12.4.1. Hospital Pharmacies
12.5. Market Value Forecast By Age Group, 2018–2030
12.6. Market Value Forecast By Country, 2018–2030
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Vaccine
12.7.2. By Product
12.7.3. By Distribution Channel
12.7.4. By Age Group
12.7.5. By Country
13. Asia Pacific Human Vaccine Market Analysis and Forecast
13.2. Market Value Forecast By Vaccine, 2018–2030
13.3. Market Value Forecast By Product, 2018–2030
13.3.7. Measles and Rubella
13.4. Market Value Forecast By Distribution Channel, 2018–2030
13.4.1. Hospital Pharmacies
13.5. Market Value Forecast By Age Group, 2018–2030
13.6. Market Value Forecast By Country, 2018–2030
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Vaccine
13.7.2. By Product
13.7.3. By Distribution Channel
13.7.4. By Age Group
13.7.5. By Country
14. Latin America Human Vaccine Market Analysis and Forecast
14.2. Market Value Forecast By Vaccine, 2018–2030
14.3. Market Value Forecast By Product, 2018–2030
14.3.7. Measles and Rubella
14.4. Market Value Forecast By Distribution Channel, 2018–2030
14.4.1. Hospital Pharmacies
14.5. Market Value Forecast By Age Group, 2018–2030
14.6. Market Value Forecast By Country, 2018–2030
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Vaccine
14.7.2. By Product
14.7.3. By Distribution Channel
14.7.4. By Age Group
14.7.5. By Country
15. Middle East & Africa Human Vaccine Market Analysis and Forecast
15.2. Market Value Forecast By Vaccine, 2018–2030
15.3. Market Value Forecast By Product, 2018–2030
15.3.7. Measles and Rubella
15.4. Market Value Forecast By Distribution Channel, 2018–2030
15.4.1. Hospital Pharmacies
15.5. Market Value Forecast By Age Group, 2018–2030
15.6. Market Value Forecast By Country, 2018–2030
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Vaccine
15.7.2. By Product
15.7.3. By Distribution Channel
15.7.4. By Age Group
15.7.5. By Country
16. Competition Landscape
16.1. Market Share Analysis By Company (2019)
16.2. Company Profiles
16.2.1. AstraZeneca plc
22.214.171.124. Company Overview (HQ, Business Segments, Employee Strength)
126.96.36.199. Growth Strategies
188.8.131.52. SWOT Analysis
16.2.2. Bavarian Nordic
184.108.40.206. Company Overview (HQ, Business Segments, Employee Strength)
220.127.116.11. Growth Strategies
18.104.22.168. SWOT Analysis
16.2.3. Bharat Biotech
22.214.171.124. Company Overview (HQ, Business Segments, Employee Strength)
126.96.36.199. Growth Strategies
188.8.131.52. SWOT Analysis
16.2.4. CSL Limited
184.108.40.206. Company Overview (HQ, Business Segments, Employee Strength)
220.127.116.11. Growth Strategies
18.104.22.168. SWOT Analysis
16.2.5. Emergent BioSolutions, Inc.
22.214.171.124. Company Overview (HQ, Business Segments, Employee Strength)
126.96.36.199. Growth Strategies
188.8.131.52. SWOT Analysis
16.2.6. GlaxoSmithKline plc.
184.108.40.206. Company Overview (HQ, Business Segments, Employee Strength)
220.127.116.11. Growth Strategies
18.104.22.168. SWOT Analysis
16.2.7. Johnson & Johnson
22.214.171.124. Company Overview (HQ, Business Segments, Employee Strength)
126.96.36.199. Growth Strategies
188.8.131.52. SWOT Analysis
16.2.8. Merck & Co, Inc.
184.108.40.206. Company Overview (HQ, Business Segments, Employee Strength)
220.127.116.11. Growth Strategies
18.104.22.168. SWOT Analysis
22.214.171.124. Company Overview (HQ, Business Segments, Employee Strength)
126.96.36.199. Growth Strategies
188.8.131.52. SWOT Analysis
16.2.10. Novartis AG
184.108.40.206. Company Overview (HQ, Business Segments, Employee Strength)
220.127.116.11. Growth Strategies
18.104.22.168. SWOT Analysis
16.2.11. Pfizer, Inc.
22.214.171.124. Company Overview (HQ, Business Segments, Employee Strength)
126.96.36.199. Growth Strategies
188.8.131.52. SWOT Analysis
16.2.12. Sanofi S.A.
184.108.40.206. Company Overview (HQ, Business Segments, Employee Strength)
220.127.116.11. Growth Strategies
18.104.22.168. SWOT Analysis
16.2.13. Shenzhen Kangtai Biological Products Co., Ltd.
22.214.171.124. Company Overview (HQ, Business Segments, Employee Strength)
126.96.36.199. Growth Strategies
188.8.131.52. SWOT Analysis
16.2.14. Takeda Pharmaceutical Company Limited
184.108.40.206. Company Overview (HQ, Business Segments, Employee Strength)
220.127.116.11. Growth Strategies
18.104.22.168. SWOT Analysis